How did the AstraZeneca-Oxford Covid-19 vaccine go from ‘game changer’ to ‘under review’?

Apr 10, 2021 | INVESTING

Cheap, highly effective and easier to distribute than rival jabs, the AstraZeneca-Oxford vaccine was hailed as a game-changer in the global fight against Covid-19.Months after it was first approved for use in Britain in December, a public relations crisis over extremely rare side effects threatens to derail vaccination efforts in numerous Asia-Pacific and lower-income countries. Countries across the European Union and Britain have already imposed age restrictions on the use of the shot,…

Read More

Pin It on Pinterest